Company documents    

Statute
Rules of the Management Board of Genomed S.A.
By-laws of the Supervisory Board of Genomed S.A.
The Regulations of the General Assembly of Genomed S.A.

Company Data

Genomed joint-stock company
Company registered by the District Court for the city of Warszawa in Warszawa,13th Commercial Division, National Court Register No. 0000374741
Share capital PLN 132 130.10
Vat No. PL7010083563
REGON 141108082
Address Poland, Warsaw, 02-971, ul. Ponczowa 12
Phone +48 22 644 60 19
email This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Account No.
BNP Paribas S.A. 56 1600 1374 0003 0052 0282 6001
IBAN: PL56 1600 1374 0003 0052 0282 6001
BIC/SWIFT CODE: PPAB PLPK

EURO Account No.
BNP Paribas S.A. 71 1600 1374 0003 0052 0282 6022
IBAN: PL71 1600 1374 0003 0052 0282 6022
BIC/SWIFT CODE: PPAB PLPK

USD Account No.
BNP Paribas S.A.  98 1600 1374 0003 0052 0282 6021
IBAN: PL98 1600 1374 0003 0052 0282 6021
BIC/SWIFT CODE: PPAB PLPK

Management Board

Anna Boguszewska-Chachulska, Chief Executive Officer cv
Marek Zagulski, Member of the Board of Directors cv

Manner of Representation

The Company may be represented by either two members of the board of directors that act jointly or a member of the board of directors acting jointly with an authorized person.

Supervisory board

Tomasz Bykowski cv
Grzegorz Piotr Gromada cv
Mieczysław Prószyński - chairman of the Supervisory Board cv
Piotr Mariusz Skowron cv
Jakub Swadźba cv

Shareholders

Shareholders	No of Shares	No of Voices	%of stock	%of voices
Diagnostyka S.A.	594 206	594 206	44,97%	30,94%
Marek Zagulski	262 808	524 808	19,89%	27,32%
Anna Boguszewska – Chachulska	119 785	229 285	9,07%	11,94%
Andrzej Pałucha	65 420	130 840	4,95%	6,81%
Iwona Wach	74 000	148 000	5,60%	7,71%
Andrzej Migdalski	65 498	129 498	4,96%	6,74%
other series A1 actions	47 275	80 355	3,58%	3,74%
series A2 actions	35 916	35 916	2,72%	1,87%
other series B actions	56 393	56 393	4,27%	2,94%

The share capital creates  1.219.000 shares of series A and 102.301 shares of series B, a total of 1.321.301.
The nominal value of each share is PLN 0.10.